A cross-sectional study of constipation and laxative use in advanced cancer patients: insights for revision of current practice
Menée en Chine auprès de 225 patients atteints d'un cancer de stade avancé et traités dans des unités de soins palliatifs, cette étude transversale évalue la prévalence des symptômes de constipation et l'utilisation de laxatifs
Purpose This study aimed to evaluate the bowel habit and laxative use in advanced cancer patients with constipation in palliative care unit. Methods It was a cross-sectional study using a self-designed questionnaire. Results A total of 225 patients were analysed. Among all patients, 92.0 % (207 patients) had any intervention for relief of constipation, including laxatives, suppositories, enemas, digital evacuation and Chinese herbal medicine, and 65.3 % (147 patients) were on laxatives prescribed by our doctors. The severity of constipation as assessed by the constipation visual analogue scale (CVAS) (0–7, 7 = most severe) was reported as no constipation (0–1) in 19.6 % of patients, constipation (2–4) in 50.7 % and severe constipation (5–7) in 29.8 %. More patients with severe constipation, as compared with patients with constipation and no constipation, reported inadequate pushing force (83.6 vs. 47.4 vs. 6.8 %), sense of incomplete defecation (40.3 vs. 14.9 vs. 6.8 %) and difficult defecation (58.2 vs. 26.3 vs. 0 %), all p < 0.001, but there was no difference in stool types as assessed by Bristol Stool Scale ( p = 0.303). Patients not on opioids, as compared with patients on strong opioids, had similar CVAS scores and description of constipation but had least laxatives prescribed (60.2 vs. 78.9 %, p = 0.012). Conclusion Evaluation of constipation should not rely on stool form or consistency alone, and patient's description of constipation is worth consideration. Constipation is also a problem in patients not on opioids and more attention is required. A revisit to existing guidelines is needed.